 |
|
|
|
|
|
 |
They said it! "Deadly accurate!" customer interviews.
"The biggest advance in 50 years in preparation of PAP smears."
"The ThinPrep PapTest is "significantly more effective" than the traditional PAP smear, improving detection ... by 65%."
"ITRAN was a failure. It was not a lot of fun. The close friends and I who founded ITRAN together are no longer speaking to each other." [ITRAN suffered from a Marketing/Engineering Investment Ratio™ (M/E Ratio™) of 0.05.]
"We didn't plan it that way [for Cytyc to invest 1.5 times as much in Market Research as in engineering]. We just did what we had to do. In retrospect, it would have been helpful to have such a planning tool. We didn't think in those terms [of the Marketing/Engineering Ratio™] at the time. We just did what was necessary to launch Cytyc successfully. Now, we have a budgeting tool in the M/E Ratio™."
"I invested only in Market Research when I launched Helicos BioSciences for single-molecule DNA sequencing in 2003. I invested $400K in cash and nearly one man-year in front-end market research and in market validation before commencing any engineering development whatsoever. Armed with a validated business opportunity, Helicos raised $27 million in Venture Capital in six weeks."
|
